MedPAC Wants Strong Working Relationship With Independent Payment Advisory Board, Director Says
This article was originally published in The Pink Sheet Daily
Medicare Payment Advisory Commission Executive Director Mark Miller discusses his view of how the group will interact with the new Medicare cost-control board established by the health care reform law.
You may also be interested in...
The Independent Payment Advisory Board is likely to take three approaches to reining in drug costs under Medicare, according to American Enterprise Institute Resident Fellow Scott Gottlieb.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.